These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3839943)

  • 21. Platelets and coagulation proteins.
    Walsh PN
    Fed Proc; 1981 May; 40(7):2086-91. PubMed ID: 6785110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A standardized bioassay for platelet factor 3 released by kaolin.
    Pérez-Requejo JL
    Br J Haematol; 1976 May; 33(1):39-51. PubMed ID: 1268089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the availability of platelet factor 3 by increased concentration of lecithin in platelets caused by gonadal steroids.
    Lillienberg L; Korsan-Bengtsen K; Olausson M; Svanborg A
    Thromb Res; 1981 Jun 1-25; 22(5-6):579-91. PubMed ID: 7302906
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationships between platelets and coagulation factors in hemostasis.
    Majerus PW; Miletich JP
    Annu Rev Med; 1978; 29():41-9. PubMed ID: 348040
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence that washed human platelets possess factor-X activator activity.
    Semeraro N; Vermylen J
    Br J Haematol; 1977 May; 36(1):107-15. PubMed ID: 871415
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.
    Tracy PB; Giles AR; Mann KG; Eide LL; Hoogendoorn H; Rivard GE
    J Clin Invest; 1984 Oct; 74(4):1221-8. PubMed ID: 6480825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet antibody determination by platelet factor 3 assay (comparison with radiolabelled serotonin release and platelet aggregometry).
    Leone G; Breda M; Accorrà F; Bizzi B
    Ric Clin Lab; 1978; 8(3):141-7. PubMed ID: 746295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet factor 3-A time (PF3-A time) in uraemia.
    Dhar JM; Rizvi SN; Rani S; Goel RG; Gulati PD
    Indian J Med Res; 1981 Apr; 73():571-6. PubMed ID: 7262929
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of platelets by platelet activating factor (PAF) derived from IgE-sensitized basophils. IV. PAF does not activate platelet factor 3 (PF3).
    Henson PM; Landes RR
    Br J Haematol; 1976 Oct; 34(2):269-82. PubMed ID: 974040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of pregnancy on the activation factors of blood coagulation and on thrombocytes].
    Tismer R; Egli H; Schander K
    Z Geburtshilfe Perinatol; 1972 Jun; 176(3):183-92. PubMed ID: 5070000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood platelet proteases and their role in platelet protein degradation and platelet coagulation factor inactivation].
    Ostrowska H; Worowski K
    Acta Haematol Pol; 1981; 12(1):17-21. PubMed ID: 7032177
    [No Abstract]   [Full Text] [Related]  

  • 33. Factor V: a platelet cytoskeletal associated protein.
    Tuszynski GP; Walsh PN
    Haematologia (Budap); 1984; 17(1):67-76. PubMed ID: 6427071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the clot-promoting activity of human platelets in a one-stage prothrombinase assay.
    Bevers EM; Comfurius P; Hemker HC; Zwaal RF
    Haemostasis; 1982; 12(3):268-74. PubMed ID: 7141305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of thrombin-induced release and activation of platelet factor V.
    Baruch D; Hemker HC; Lindhout T
    Eur J Biochem; 1986 Jan; 154(1):213-8. PubMed ID: 2417835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor V binding to human platelets: the role of divalent cations and of platelet preparatory methods.
    Ittyerah TR; Rawala R; Colman RW
    Thromb Res; 1982 Apr; 26(1):59-71. PubMed ID: 7101247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.
    Osterud B; Rapaport SI; Lavine KK
    Blood; 1977 May; 49(5):819-34. PubMed ID: 851644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PF3 activity in normal subjects and beta-thalassemia trait.
    Timan IS; Funahara Y; Setiabudy R; Latu J; Silman E
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():216-8. PubMed ID: 7886579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the coagulant activities of platelets and phospholipids.
    Walsh PN; Lipscomb MS
    Br J Haematol; 1976 May; 33(1):9-18. PubMed ID: 1268092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.
    Kirchhof B; Balleisen L
    Thromb Res; 1982 Aug; 27(3):303-10. PubMed ID: 6890246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.